cagrilintide clinical trials results Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study cagrilintide semaglutide combination trial Cagrilintide–semaglutide
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
00125-7/asset/25d10da2-038c-4d13-b485-c9856810af68/main.assets/gr3_lrg.jpg)


